๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas

โœ Scribed by J. Russell Geyer; Clinton F. Stewart; Mehmet Kocak; Alberto Broniscer; Peter Phillips; James G. Douglas; Susan M. Blaney; Roger J. Packer; Sri Gururangan; Anu Banerjee; Mark W. Kieran; Larry E. Kun; Richard J. Gilbertson; James M. Boyett


Book ID
116430470
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
291 KB
Volume
46
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of children with newly diagnos
โœ Roger J. Packer; Michael Prados; Peter Phillips; H. Stacy Nicholson; James M. Bo ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 721 KB

## BACKGROUND. Prognosis for the majority of children with brain stem gliomas is dismal. In previous studies, recombinant beta-interferon (@IF) has been shown to be effective for children with recurrent brain stem gliomas and may also act synergistically with radiotherapy (RT). ## METHODS. Thir

A Phase I study of concurrent RMP-7 and
โœ Roger J. Packer; Mark Krailo; Minesh Mehta; Katherine Warren; Jeffrey Allen; Reg ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB

## Abstract ## BACKGROUND Ninety percent of children with diffuse, intrinsic brainstem tumors will die within 18 months of diagnosis. Radiotherapy is of transient benefit to these children, and a potential way to improve its efficacy is to add radiosensitizers. Carboplatin is antineoplastic and ra

Carboplatin and etoposide with hyperfrac
โœ Walter, Andrew W.; Gajjar, Amar; Ochs, Judith S.; Langston, James W.; Sanford, R ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 2 views

## Background: Diffuse pontine gliomas remain one of the most lethal of pediatric malignancies despite the use of increasingly intensive therapies. we delivered intensive chemotherapy during and following 70.2 gy of hyperfractionated radiation therapy in an attempt to improve survival. ## Procedur